# Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Study · id `cardio:ct-nct03568890` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03568890](<https://clinicaltrials.gov/study/NCT03568890>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03568890

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 510 participants.

## Technical summary

Registry record NCT03568890. Randomized; no masking; primary purpose prevention. Start 2018-09-01 (actual); primary completion 2025-08-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 510 participants (planned count; ClinicalTrials.gov record NCT03568890, source copy `cardio:ctgov-nct03568890-2026-03-27`, retrieved 2026-10-26)
- Started: 2018-09-01 (actual) (ClinicalTrials.gov record NCT03568890, source copy `cardio:ctgov-nct03568890-2026-03-27`, retrieved 2026-10-26)
- Primary completion: 2025-08-01 (actual) (ClinicalTrials.gov record NCT03568890, source copy `cardio:ctgov-nct03568890-2026-03-27`, retrieved 2026-10-26)
- Completion: 2030-09-01 (anticipated) (ClinicalTrials.gov record NCT03568890, source copy `cardio:ctgov-nct03568890-2026-03-27`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT03568890, source copy `cardio:ctgov-nct03568890-2026-03-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03568890-2026-03-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
- Acronym: ANDES
- Condition: Left Atrial Appendage Closure
- Condition: Thrombosis
- Condition: Stroke
- Condition: TIA
- Condition: Bleeding
- Intervention (Drug): Rivaroxaban, dabigatran, apixaban, or edoxaban
- Intervention (Drug): Clopidogrel -75 mg/day
- Intervention (Drug): Low dose aspirin -80 to 125 mg/day-
- Lead sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec (`cardio:org-centre-de-recherche-de-l-institut-universitaire-de-17cd1e`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial (`cardio:pubmed-41139402`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0f598330ffc91c33f3c6705087853411bcdcb57422df722677e5ab2115eee50f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
